Pfizer Inc. (PFE) - 5i Research

Pfizer Inc. (PFE $24.88)
- $24.88 P/E (TTM): 14.65X Cap: $141.46B
- View PFE Profile
- View Questions on PFE

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Pfizer Inc. (PFE $24.88)
- $24.88 P/E (TTM): 14.65X Cap: $141.46B
- View PFE Profile
- View Questions on PFE

Q: Regarding Pfizer, from a risk/reward perspective, do you see potential in this beaten up stock? It looks cheap to my amateur eyes.

Thanks as always for your expertise.

Read Answer Asked by Richard on December 19, 2025

Gilead Sciences Inc. (GILD $125.19)
- $125.19 P/E (TTM): 19.24X Cap: $155.32B
- View GILD Profile
- View Questions on GILD
Abbott Laboratories (ABT $124.54)
- $124.54 P/E (TTM): 15.74X Cap: $216.55B
- View ABT Profile
- View Questions on ABT
Merck & Company Inc. (MRK $105.04)
- $105.04 P/E (TTM): 13.36X Cap: $259.91B
- View MRK Profile
- View Questions on MRK
Pfizer Inc. (PFE $24.88)
- $24.88 P/E (TTM): 14.65X Cap: $141.46B
- View PFE Profile
- View Questions on PFE

Q: Would you recommend starting a new position now in these big pharma stocks with rotation out of the tech sector lately? All three have decent PE, PEG and PS ratios and have been fared well in last few bear markets overall. What would your recommended allocation be across the three stocks for an investment of time line of 5 years?
Thanks!

Read Answer Asked by Scott on December 17, 2025

Merck & Company Inc. (MRK $105.04)
- $105.04 P/E (TTM): 13.36X Cap: $259.91B
- View MRK Profile
- View Questions on MRK
Pfizer Inc. (PFE $24.88)
- $24.88 P/E (TTM): 14.65X Cap: $141.46B
- View PFE Profile
- View Questions on PFE
GSK plc American Depositary Shares (Each representing two) (GSK $48.85)
- $48.85 P/E (TTM): 29.39X Cap: $98.74B
- View GSK Profile
- View Questions on GSK
Dynavax Technologies Corporation (DVAX $11.13)
- $11.13 Cap: $1.26B
- View DVAX Profile
- View Questions on DVAX

Q: I understand there has been some type of study which shows people who have taken the Shingles vaccine are less likely to develop Alzheimer’s like diseases. The scientific community seems not to know why this is so. There are a lot of unknowns on this study to say the least. Do you know any first rate Pharma companies that are leaders in the development and manufacturing the Shingles vaccines? I know there are a number of Shingles vaccines out in the marketplace, probably made by different companies. Does Bloomberg have anything to say on the subject? Any thoughts you have would be appreciated.
Jim

Read Answer Asked by James on December 04, 2025